HZNP — Horizon Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge Cap

Annual balance sheet for Horizon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	959	1,076	2,080	1,580	2,353
Net Total Accounts Receivable
Net Total Receivables	465	409	660	633	676
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,546	1,686	3,070	2,800	3,653
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.1	70	223	368	440
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	3,942	4,436	6,073	8,678	9,115
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	709	723	876	887	949
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	2,752	2,251	2,047	4,005	4,042
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,190	2,185	4,025	4,672	5,072
Total Liabilities & Shareholders' Equity	3,942	4,436	6,073	8,678	9,115
Total Common Shares Outstanding